Our comprehensive meta‐analysis brought to light that the expression of TP53 mutation was obviously related to progression with Ta stage or NMIBC, TP53 mutation was probably a potential diagnosis marker in advanced bladder cancer. The gene discussed is TP53; the disease is urinary bladder carcinoma.